Archives
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2019-07
- 2018-07
-
Cy5 NHS ester(Et): Technical Guidance for Protein Labeling
2026-07-07
Cy5 NHS ester(Et) enables efficient, water-soluble fluorescent labeling of amino groups in proteins and biomolecules for applications such as immunofluorescence, flow cytometry, and fluorescence microscopy. It should not be used in ethanol-based protocols or in workflows requiring long-term storage of dye solutions. This guide details best practices for reliable assay setup and troubleshooting.
-
Merbromin Selectively Inhibits SARS-CoV-2 3CLpro Protease Ac
2026-07-07
Chen et al. identify Merbromin as a potent, selective mixed-type inhibitor of the SARS-CoV-2 main protease (3CLpro), using high-throughput screening of ~6,000 compounds. Their rigorous enzymology shows Merbromin's inhibition is highly specific to 3CLpro and does not affect broad-spectrum serine proteases like Proteinase K, highlighting new avenues for antiviral inhibitor design.
-
Lithium-Driven Exosomal Wnt10a Secretion Enhances Osteogenes
2026-07-06
This study elucidates how lithium stimulates osteogenesis via Rab11a-mediated exosomal Wnt10a secretion and subsequent activation of Wnt/β-catenin signaling in bone mesenchymal stem cells (BMSCs). These mechanistic insights advance the understanding of bone regeneration and open new avenues for engineering exosome-based therapies and small-molecule interventions in regenerative medicine.
-
Troglitazone as a PPARγ Agonist: Expanding Horizons in Tumor
2026-07-06
Explore Troglitazone’s distinct role as a PPARγ agonist in modulating the tumor microenvironment and advancing type 2 diabetes research. This article delivers in-depth scientific analysis and actionable insights, setting it apart from existing content.
-
Caspase 3/7 Drive Cytoprotective Autophagy in Breast Cancer
2026-07-05
Samarasekera et al. uncover that caspase 3 and caspase 7 support autophagy and the DNA damage response during non-lethal stress in human breast cancer cells. This work reveals a conserved, non-apoptotic function for effector caspases in stress adaptation, offering new angles for therapeutic targeting and functional assays.
-
Propranolol Modulates Metabolic Pathways After Severe Burn I
2026-07-04
This article analyzes a phase II randomized controlled trial that uncovers how propranolol, a nonselective beta-blocker, normalizes adipose tissue metabolomic signatures in patients with severe burns. The study links these metabolic changes to improved clinical outcomes, offering mechanistic insights into burn-induced hypermetabolism and highlighting implications for future metabolism research.
-
Streptavidin-Cy3: Advancing Biotin Detection in Translationa
2026-07-03
This article explores the mechanistic and translational value of Streptavidin-Cy3 for high-sensitivity biotin detection in metastatic cancer research, integrating recent discoveries on super-enhancer RNA-driven metastasis in nasopharyngeal carcinoma and providing actionable guidance for protocol optimization.
-
Itraconazole in Antifungal Resistance: Mechanistic Insights
2026-07-03
Explore how Itraconazole, a triazole antifungal agent, advances research into Candida biofilm resistance and drug interaction studies. Discover unique mechanistic insights and practical assay implications distinct from standard antifungal protocols.
-
Proteinase K: Broad-Spectrum Serine Protease in DNA Isolatio
2026-07-02
Proteinase K from APExBIO sets the benchmark for DNA isolation workflows by combining high activity, robust contaminant removal, and uncompromised DNA integrity. This article delivers protocol enhancements, troubleshooting insights, and application-driven guidance for maximizing the enzyme’s power in your molecular biology lab.
-
Epinephrine Bitartrate: Protocols and Solutions for Research
2026-07-02
Epinephrine Bitartrate (SKU B1358) is a high-purity, non-selective adrenergic receptor agonist that empowers both cell-based and in vivo research with reproducible, tunable adrenergic signaling. This article details experimental protocols, translational use-cases, and troubleshooting strategies to maximize reliability when leveraging this APExBIO compound across cardiovascular, neurobiology, and clinical-assay domains.
-
AM 281: CB1 Cannabinoid Receptor Antagonist in Neuropharmaco
2026-07-01
AM 281 empowers researchers to dissect CB1-mediated signaling with unmatched selectivity, enabling robust investigations into cognitive dysfunction and neuroprotection. This guide translates cutting-edge evidence into actionable workflows, troubleshooting strategies, and comparative insights—optimizing your use of AM 281 for advanced neuropharmacology research.
-
Roscovitine (Seliciclib): Precision CDK Inhibition in Cancer
2026-07-01
Roscovitine (Seliciclib, CYC202) stands out as a selective cyclin-dependent kinase inhibitor for dissecting cell cycle arrest and tumor growth inhibition. This guide details experimental workflows, optimization strategies, and troubleshooting grounded in both reference cheminformatics and hands-on protocol expertise.
-
Radiopathomics Signature Enhances Immunotherapy Prediction i
2026-06-30
A recent study developed a multimodal radiopathomics signature (RPS) integrating CT and digital pathology data to accurately predict immunotherapy response in gastric cancer. This machine learning-based approach outperformed traditional biomarkers and offers a robust tool for stratifying patient risk and guiding precision oncology.
-
AMG 487: Precision CXCR3 Antagonist for Macrophage Polarizat
2026-06-30
AMG 487 delivers highly selective CXCR3 antagonism, allowing researchers to modulate macrophage polarization with state-dependent precision. This potent tool from APExBIO empowers advanced studies in inflammation, autophagy, and acute lung injury models, with practical workflow guidance and troubleshooting insights.
-
Proteinase K (K1037): Reliable Solutions for DNA Integrity
2026-06-29
This scenario-driven article addresses key laboratory challenges in cell viability and DNA preparation, highlighting how Proteinase K (SKU K1037) delivers reproducible, contaminant-free results. Drawing on quantitative data and peer-reviewed studies, we illustrate workflow optimizations and practical guidance for biomedical researchers using this broad-spectrum serine protease.